Published in Mol Cell Endocrinol on July 31, 2002
Alternatively spliced androgen receptor variants. Endocr Relat Cancer (2011) 2.41
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47
Posttranslational modification of the androgen receptor in prostate cancer. Int J Mol Sci (2013) 1.16
Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J Exp Clin Cancer Res (2013) 1.01
DACH1, a zona glomerulosa selective gene in the human adrenal, activates transforming growth factor-β signaling and suppresses aldosterone secretion. Hypertension (2015) 0.95
Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients. Breast Cancer Res Treat (2011) 0.83
ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS One (2011) 0.80
Clinical profile, BRCA2 expression, and the androgen receptor CAG repeat region in Egyptian and Moroccan male breast cancer patients. Breast Dis (2011) 0.80
Androgen receptor CAG repeat length and risk of biliary tract cancer and stones. Cancer Epidemiol Biomarkers Prev (2010) 0.78
Long CAG repeat sequence and protein expression of androgen receptor considered as prognostic indicators in male breast carcinoma. PLoS One (2012) 0.78
Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility. Evol Appl (2012) 0.78
TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science (2008) 8.74
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials. J Natl Cancer Inst (2007) 4.14
Antiangiogenic activity of the MDM2 antagonist nutlin-3. Circ Res (2006) 1.96
Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol (2007) 1.87
Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: role of pendrin and anion channels. J Immunol (2007) 1.35
Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J Endocrinol (2006) 1.32
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival. Eur J Cancer (2009) 1.29
Metastasis signatures: genes regulating tumor-microenvironment interactions predict metastatic behavior. Cancer Metastasis Rev (2008) 1.28
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol (2004) 1.28
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines. Endocr Relat Cancer (2007) 1.24
Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol (2006) 1.23
The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem (2007) 1.21
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets. FASEB J (2005) 1.19
Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. Carcinogenesis (2007) 1.15
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J Neuroimmunol (2004) 1.09
Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab (2004) 1.08
Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung. Carcinogenesis (2010) 1.08
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. Cell Cycle (2013) 1.03
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression. PLoS One (2012) 1.01
Paradoxic effects of metformin on endothelial cells and angiogenesis. Carcinogenesis (2014) 1.00
Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab (2004) 0.99
Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis (2012) 0.99
The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide. Clin Cancer Res (2005) 0.98
Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Mod Pathol (2006) 0.98
Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling. Am J Physiol Cell Physiol (2011) 0.98
Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II. Sci Rep (2013) 0.96
Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo. Int J Cancer (2011) 0.95
SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med (2009) 0.95
Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. J Clin Endocrinol Metab (2012) 0.93
Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung. Mutat Res (2010) 0.91
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo. Cancer Gene Ther (2004) 0.91
Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr Pharm Des (2008) 0.90
Up-regulation of advanced glycated products receptors in the brain of diabetic rats is prevented by antioxidant treatment. Endocrinology (2005) 0.90
Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep (2007) 0.90
Epigenetics modifications and therapeutic prospects in human thyroid cancer. Front Endocrinol (Lausanne) (2012) 0.89
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel. Cancer Metastasis Rev (2014) 0.89
Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study. Br J Nutr (2011) 0.89
A prognostic multigene classifier for squamous cell carcinomas of the larynx. Cancer Lett (2011) 0.88
Survival Online: a web-based service for the analysis of correlations between gene expression and clinical and follow-up data. BMC Bioinformatics (2009) 0.88
Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells. PLoS One (2011) 0.88
Inhibition of Kaposi's sarcoma in vivo by fenretinide. Clin Cancer Res (2003) 0.88
Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates. Am J Pathol (2003) 0.87
Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. Life Sci (2003) 0.87
Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells. Int J Oncol (2002) 0.87
Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells. BMC Cancer (2012) 0.86
Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses. Mutat Res (2005) 0.86
Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells. Thyroid (2013) 0.86
Emerging molecular therapies of advanced thyroid cancer. Mol Aspects Med (2010) 0.86
PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma. PLoS One (2010) 0.85
Lineage infidelity and expression of melanocytic markers in human breast cancer. Int J Oncol (2008) 0.85
Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression. Carcinogenesis (2006) 0.85
Evidence that fibulin family members contribute to the steroid-dependent extravascular sequestration of sex hormone-binding globulin. J Biol Chem (2006) 0.85
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer. Carcinogenesis (2009) 0.84
Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J Nucl Med (2013) 0.84
Reference profile correlation reveals estrogen-like trancriptional activity of Curcumin. Cell Physiol Biochem (2010) 0.84
Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol Cancer (2009) 0.84
Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy. Endothelium (2002) 0.82
Transcriptional control of cell density dependent regulation of matrix metalloproteinase and TIMP expression in breast cancer cell lines. Thromb Haemost (2005) 0.82
Alternative splicing of the human estrogen receptor alpha primary transcript: mechanisms of exon skipping. Int J Mol Med (2003) 0.82
High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cells. Breast Cancer Res Treat (2003) 0.82
IGF1 regulates PKM2 function through Akt phosphorylation. Cell Cycle (2015) 0.82
Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by Gefitinib and Cetuximab triggered antibody-dependent cellular cytotoxicity. Eur J Cancer (2013) 0.82
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients. Mol Cancer (2013) 0.81
ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion. Pigment Cell Melanoma Res (2014) 0.80
Novel aspects for the application of Curcumin in chemoprevention of various cancers. Front Biosci (Schol Ed) (2010) 0.80
Early response of gene clusters is associated with mouse lung resistance or sensitivity to cigarette smoke. Am J Physiol Lung Cell Mol Physiol (2008) 0.80
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. Clin Exp Metastasis (2010) 0.79
Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation. J Biol Chem (2002) 0.79
Demethyl fruticulin A (SCO-1) causes apoptosis by inducing reactive oxygen species in mitochondria. J Cell Biochem (2010) 0.78
Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125. Biochem Pharmacol (2012) 0.78
Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib. Oncol Rep (2009) 0.78
Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia. Int J Oncol (2003) 0.78
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. Cancer Lett (2009) 0.77
A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets. J Natl Cancer Inst (2006) 0.77
Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries. Biol Chem (2002) 0.77
Effects of bicalutamide and 4OH-tamoxifen on androgen-regulated gene expression in the LNCaP cell line. Anticancer Res (2012) 0.76
Inhibition of a vascular ocular tumor growth by IL-12 gene transfer. Clin Exp Metastasis (2007) 0.76
Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure. Breast Cancer Res Treat (2008) 0.76
Meningiomas after cranial radiotherapy for childhood cancer: a single institution experience. J Cancer Res Clin Oncol (2015) 0.76
Re: Microarray studies challenge theories of metastasis. J Natl Cancer Inst (2003) 0.75
Thyroid Autoimmunity and Cancer. Front Horm Res (2017) 0.75